Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT06946732

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Led by RenJi Hospital · Updated on 2025-04-27

127

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

Sponsors

R

RenJi Hospital

Lead Sponsor

X

Xiamen Cardiovascular Hospital, Xiamen University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.

CONDITIONS

Official Title

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 85 years
  • Clinical symptoms and presentation consistent with pulmonary embolism
  • Pulmonary embolism symptoms lasting 14 days or less
  • High-risk pulmonary embolism patients with absolute contraindications to systemic thrombolysis or failure of thrombolysis, not eligible for surgical embolectomy
  • Intermediate-high risk pulmonary embolism patients with right ventricle dysfunction (right ventricle/left ventricle ratio > 0.9) confirmed by computed tomography pulmonary angiography or transthoracic echocardiography
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Refusal to sign informed consent
  • Presence of intracardiac thrombus
  • Chronic left heart failure with ejection fraction below 30%
  • Diagnosed thrombophilia
  • History of severe or chronic pulmonary hypertension
  • Serum creatinine level higher than 1.8 mg/dl
  • Known serious and uncontrolled sensitivity to radiographic agents

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Renji Hospital

Shanghai, Shanghai Municipality, China, 200217

Actively Recruiting

Loading map...

Research Team

Q

Qihong Ni

CONTACT

M

Meng Ye

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here